Stock_Titan Posted - 2 hours ago

$UTHR United Therapeutics Announces World’s First Successful Xenothymokidney Transplant https://www.stocktitan.net/news/UTHR/united-therapeutics-announces-world-s-first-successful-brbzup313e2x.html

Stock_Titan Posted - 4 hours ago

$UTHR United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024 https://www.stocktitan.net/news/UTHR/united-therapeutics-corporation-to-report-first-quarter-2024-h6og8a3x14kh.html

insiderbuyingselling Posted - 9 hours ago

$UTHR new insider selling: 7200 shares. http://insiderbuyingselling.com/?t=UTHR

mangothegreat Posted - 19 hours ago

$MNKD and $UTHR are up today while $LQDA is down. Is this not the ”big” day for Liquidia? The Street must not think so!

UncleStock Posted - 1 day ago

$CORT $UTHR $EXEL $VRTX suggested for $BTK US ARCA Biotechnology - value screen: https://zpr.io/tWJwE

Outcomes Posted - 5 days ago

$MNKD $UTHR

basedman Posted - 5 days ago

@Preacherclint10 you got big balls shorting a company thats expecting FDA approval and launch within the month. especially after news of the judge having enough of $UTHR games. ill be happy to take your money though.

neuroinvestor3 Posted - 1 week ago

$UTHR Hopefully the 2.8M shares of $CLNN that UTHR holds will appreciate today... https://invest.clene.com/news-releases/news-release-details/evidence-clenes-cnm-au8r-treatment-repair-and-remyelination

Outcomes Posted - 1 week ago

$MNKD $UTHR 'TETON Phase 3 Clinical Trials of Inhaled Treprostinil in the Treatment of Idiopathic Pulmonary Fibrosis: Annual Update of Preliminary Baseline Data' “We look forward to presenting the latest data on several of our key products and development programs,”. “Notably, our academic and industry collaborators will present initial interim efficacy data from.....the ongoing TETON studies in idiopathic pulmonary fibrosis.' https://ir.unither.com/press-releases/2024/04-16-2024-120048155

Stock_Titan Posted - 1 week ago

$UTHR United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference https://www.stocktitan.net/news/UTHR/united-therapeutics-to-feature-clinical-data-across-its-commercial-auz8wj98yuno.html

insiderbuyingselling Posted - 1 week ago

$UTHR new insider selling: 7200 shares. http://insiderbuyingselling.com/?t=UTHR

btrbio Posted - 1 week ago

$UTHR I’m curious if Martine still owns Tesla.

neuroinvestor3 Posted - 1 week ago

$CLNN The government is buying at least 7M worth of CNM-Au8 every year for the next 5 years and giving to PALS. How is that not reflected in the valuation/SP? The grant amount is almost equal to current market cap. Also, based on future PALS demand for CNM-Au8, additional NIH grant funding could be coming to Clene. Combined with $BCLI therapy, ALS mortality rate will be greatly reduced! $UTHR needs to step in and capitalize on their investment in Clene - get them over the FDA finish line!

insiderbuyingselling Posted - 1 week ago

$UTHR new insider selling: 28800 shares. http://insiderbuyingselling.com/?t=UTHR

neuroinvestor3 Posted - 2 weeks ago

$CLNN https://stkt.co/8Gha1D71 So this means a PR soon on the NIH grant? 7M is nice revenue and will extend cash runway to ALS FDA approval. Was expected news priced in? haha... maybe we see a bump up soon! Then the usual retreat.... unless $UTHR or another big brother steps in with resources to ensure CLNN survivability through the phase 3 trials. "The Subaward includes reimbursement of Company expenses for the NIH EAP in an amount up to $7.3 million during the period from September 25, 2023 to August 31, 2024. Disbursement of funds for the NIH EAP will be paid to the Company based on the Company’s submission of invoices to Colombia for reimbursement on a monthly or quarterly basis."

insiderbuyingselling Posted - 2 weeks ago

$UTHR new insider selling: 20060 shares. http://insiderbuyingselling.com/?t=UTHR

UncleStock Posted - 2 weeks ago

$CORT $UTHR $EXEL $VRTX suggested for $BTK US ARCA Biotechnology - value screen: https://zpr.io/tWJwE

TltFlush Posted - 2 weeks ago

$MNKD $UTHR

TltFlush Posted - 2 weeks ago

@rooksleanne He was young & innocent then 😊 . . Unfortunately, double jeopardy might be in store for him turning his back in an awful timing on his once cherished dream $MNKD stock . . *Paid off $33M Midcap debt *Paid off $9M Mann Group convertible notes *First ever 2 consecutive profitable quarters 🏆 *$302M in the bank 🏦 *Growing Tyvaso-DPI royalty ($UTHR partnership) & #Afrezza revenue 💰 *Imminent filings of 2 INDs for drugs that are already FDA approved & available in the market for other indications sold by Novartis (Clofazimine) & Boehringer-Ingelheim (Nintedanib) ✅ *Potential partnership from these 2 INDs 💰 *Afrezza pediatric Phase 3 trial 🏁

insiderbuyingselling Posted - 2 weeks ago

$UTHR new insider selling: 6000 shares. http://insiderbuyingselling.com/?t=UTHR

UncleStock Posted - 2 weeks ago

$CORT $UTHR $EXEL $VRTX suggested for $BTK US ARCA Biotechnology - value screen: https://zpr.io/tWJwE

TltFlush Posted - 2 weeks ago

$MNKD Facts: *Paid off $33M Midcap debt *Paid off $9M Mann Group convertible notes *2 consecutive quarters of profit 🏆 *$302M in the bank 🏦 *Growing Tyvaso-DPI royalty ($UTHR partnership) & #Afrezza revenue 💰 *Imminent filings of 2 INDs for drugs that are already FDA approved & available in the market for other indications sold by Novartis (Clofazimine) & Boehringer-Ingelheim (Nintedanib) ✅ *Potential partnership from these 2 INDs 💰 *Afrezza pediatric Phase 3 trial 🏁

Preacherclint10 Posted - 2 weeks ago

$MNKD $UTHR facts. Not mindless Fud

TltFlush Posted - 2 weeks ago

$MNKD Paid off $32M Midcap debt *Paid off $9M Mann Group convertible notes *2 consecutive quarters of profit 🏆 *$302M (approx) in the bank 🏦 *Growing Tyvaso-DPI royalty ($UTHR partnership) & #Afrezza revenue 💰 *Potential partnership from these 2 INDs 💰 *Afrezza pediatric Phase 3 trial 🏁

TRADINGCENTRAL Posted - 2 weeks ago

💼United Therapeutics Corp ($UTHR : NASDAQ) formed a Double Top on April 1, 2024. This technical pattern indicates the price seems to have reached a top, after failing to break through a resistance level and ultimately breaking downward in a sign of reversal to a new downtrend.

TltFlush Posted - 3 weeks ago

$MNKD “Can someone do something to stop the looping?” @jen011555 I don’t worry much about the looping, I would worry if these things are not what they are: *2 consecutive quarters of profit 🏆 *$302M in the bank 🏦 *Growing Tyvaso-DPI royalty ($UTHR partnership) & #Afrezza revenue 💰 *Imminent filings of 2 INDs for drugs that are already FDA approved & available in the market for other indications sold by Novartis (Clofazimine) & Boehringer-Ingelheim (Nintedanib) ✅ *Potential partnership from these 2 INDs 💰 *Afrezza pediatric Phase 3 trial 🏁

imthedamo Posted - 3 weeks ago

$LQDA Here we go! $UTHR a public benefit company my ass. They look like a bunch of desperate fools, looking for a way to destroy a company regardless of the public benefit.

briefingcom Posted - 3 weeks ago

$LQDA: Liquidia Technologies - Update on favorable legal and regulatory outcomes clearing path for potential FDA approval of YUTREPIA $UTHR https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240401060701LQDA&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

biglqdaguy Posted - 3 weeks ago

$MNKD $UTHR get ready to fucking suck !!